PedAM
Pediatric Disease Annotations & Medicines
| Disease | eosinophilia |
| Phenotype | |rash |
| Sentences | 147 |
| PubMedID- 23807893 | Drug-induced hypersensitivity syndrome (dihs), also called drug rash with eosinophilia and systemic symptoms (dress), is a severe reaction to drugs, such as carbamazepine, phenytoin, phenobarbital, allopurinol, minocycline, sulfasalazine, and dapsone, mimicking severe sepsis or viral infection. |
| PubMedID- 23114284 | We describe 11 cases of anti-tuberculosis dress (drug-related rash with eosinophilia and systemic symptoms) syndrome, a potentially serious complication of treatment that led to interruption of treatment for prolonged periods, systemic corticosteroid use and the resumption of treatment with less effective regimens. |
| PubMedID- 26213468 | Local application can avoid the potential adverse reactions, such as toxic epidermal necrolysis, drug rash with eosinophilia, and systemic symptoms syndrome.17 thus, strontium surface coating has been of increasing interest as a method for modification of chemistry to promote osseointegration. |
| PubMedID- 23487540 | It is important to keep in mind the rare dermal side effects (eg, stevens–johnson syndrome, drug rash with eosinophilia, systematic symptoms) and the risk of inducing mania, delusions, hallucinations, and/or aggression.65 in the authors’ opinion, the only possible advice so far is to reduce dopaminergic medication as far as needed and possibly switch to alternative medications as far as practicable. |
| PubMedID- 21817121 | These clinical pictures suggest drug rash with eosinophilia and systemic symptoms (dress) induced by cefotaxime. |
| PubMedID- 25897253 | There are several considerations when using systemic treatments, including allergic reactions, drug rash with eosinophilia and systemic symptoms (dress syndrome), cutaneous hyperpigmentation, benign intracranial hypertension, autoimmune hepatitis, and drug-induced lupus-like syndrome. |
| PubMedID- 20846239 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome induced by cidofovir. |
| PubMedID- 21342224 | Interestingly, this disorder is quite similar to drug-induced hypersensitivity syndrome (dihs), also referred to as drug rash with eosinophilia and systemic symptoms (dress), from the perspective of the onset of the reaction after exposure to tce/drugs, clinical manifestations, blood examination and period of virus reactivation. |
| PubMedID- 26298826 | Drug rash with eosinophilia and systemic symptoms caused by the dietary supplement diindolylmethane. |
| PubMedID- 21852061 | Background: drug rash with eosinophilia and systemic symptoms (dress) syndrome is an uncommon but serious hypersensitivity drug reaction most frequently associated with antiepileptics. |
| PubMedID- 19854669 | Drug rash with eosinophilia and systemic symptoms syndrome induced by sulfasalazine. |
| PubMedID- 22701258 | He was diagnosed as drug rash with eosinophilia and systemic symptoms (dress). |
| PubMedID- 23970584 | Shortly after commencing the drug, the patient developed a severe adverse drug reaction manifesting as drug reaction (or rash) with eosinophilia and systemic symptoms (dress) syndrome. |
| PubMedID- 21176761 | Aim: study the epidemiological, clinical, biological and chronological drug rash with eosinophilia and systemic symptoms (dress) characteristic and indicate the implicated drugs. |
| PubMedID- 20798484 | Drug rash with eosinophilia and systemic symptoms due to telaprevir. |
| PubMedID- 24060789 | One such diagnosis is drug rash with eosinophilia and systemic symptoms. |
| PubMedID- 22950030 | 2. they ranks from maculopapular exanthema to non-immediate urticaria and other less common but more severe entities such as agep, drug rash with eosinophilia and systemic symptoms, drug hypersensitivity syndrome (dhs), stevens-johnson syndrome (sjs), and toxic epidermal necrolysis (ten), fixed drug eruption and contact dermatitis as well as organ specific reactions.72,73 although maculopapular exanthema is the most common reported reaction, it can sometimes be intense, accompanied with subcutaneous angioedema, and persists for several weeks despite discontinuation of treatment.73 dhs and bullous reactions with mucosal involvement are considered severe diseases.10,72 erythema multiform, which is less severe, is usually induced by virus and characterized by the presence of typical target lesions. |
| PubMedID- 25115449 | Objective: allopurinol, an antihyperuricaemic agent, is one of the common causes of life-threatening severe cutaneous adverse reactions (scar), including drug rash with eosinophilia and systemic symptoms (dress), stevens-johnson syndrome (sjs) and toxic epidermal necrosis (ten). |
| PubMedID- 23271613 | Dress or drug reaction (or rash) with eosinophilia and systemic symptoms belongs to the severe cutaneous adverse reaction group and is characterized by hematological abnormalities and visceral organ involvement. |
| PubMedID- 19874350 | Background: drug-induced hypersensitivity syndrome (dihs)/drug rash with eosinophilia and systemic symptoms (dress) syndrome is characterized by late disease onset, fever, rash, hepatic dysfunction, haematological abnormalities, lymphadenopathy and often, human herpesvirus (hhv) reactivation. |
| PubMedID- 21658796 | Dress (drug rash with eosinophilia and systemic symptoms), also known as drug-induced hypersensitivity syndrome, is a severe, systemic drug reaction most commonly associated with aromatic anticonvulsants and sulfonamides. |
| PubMedID- 23551241 | Background: aromatic anticonvulsant-induced severe cutaneous adverse drug reactions (scars), including stevens-johnson syndrome (sjs), toxic epidermal necrosis (ten), and drug rash with eosinophilia and systemic symptoms (dress), are fatal immune-mediated adverse drug reactions. |
| PubMedID- 26420570 | Drug-induced hypersensitivity syndrome (dihs), also known as drug rash with eosinophilia and systemic symptoms (dress), is a severe adverse drug reaction [1–3]. |
| PubMedID- 21342226 | In the field of severe cutaneous adverse drug reactions (cutaneous adr) such as stevens-johnson syndrome (sjs), toxic epidermal necrolysis (ten), and drug-induced hypersensitivity syndrome (dhis) or drug rash with eosinophilia and systemic symptoms (dress), major advances have recently been gained through studies of an association between hla alleles and drug hypersensitivity induced by specific drugs. |
| PubMedID- 21314014 | Antituberculosis drug-induced drug rash with eosinophilia and systemic symptoms syndrome confirmed by patch testing. |
| PubMedID- 23075643 | Aim: to determine the prevalence, the clinical patterns of drug eruptions, and the common drugs implicated, particularly in severe cadr such as stevens-johnson syndrome/toxic epidermal necrolysis (sjs/ten) and drug rash with eosinophilia and systemic symptoms (dress) in our population. |
| PubMedID- 25938071 | Background: in vietnam, we observed a high incidence of carbamazepine (cbz)-induced severe cutaneous adverse drug reactions (scars)-stevens-johnson syndrome (sjs)/toxic epidermal necrolysis (ten), and drug-induced hypersensitivity rash with eosinophilia and systemic symptoms (dress). |
| PubMedID- 26321400 | Although the majority of cutaneous adverse drug reactions are benign and self-limiting, stevens-johnson syndrome (sjs), toxic epidermal necrolysis (ten), and drug rash with eosinophilia and systemic symptoms (dress), affecting multiple organs and systems, are potentially fatal. |
| PubMedID- 20022144 | Objective: to evaluate changes in the use of strontium ranelate following a health safety warning in november 2007 on the risks of the development of dress (drug rash with eosinophilia and systemic symptoms) with the use of this medicine. |
| PubMedID- 21597594 | Dress (drug rash with eosinophilia and systemic symptoms) syndrome is a potentially fatal and probably underrecognized complication of allopurinol. |
| PubMedID- 25097293 | Drug rash with eosinophilia and systemic symptoms syndrome, a serious condition, has been reported in association with various drugs including dapsone. |
| PubMedID- 21313995 | Background: the clinical features of drug-induced hypersensitivity syndrome (dihs) or drug rash with eosinophilia and systemic symptoms (dress) syndrome are complicated, and the incidence of this condition is very low. |
| PubMedID- 23914033 | We present the case of a 32-year-old woman who had presumptive eosinophilic myocarditis as part of a generalized hypersensitivity reaction (drug rash with eosinophilia and systemic symptoms [dress] syndrome) that exhibited a dramatic response to steroid therapy. |
| PubMedID- 22165859 | Multi-organ reactions may also occur and include anaphylaxis (a serious systemic allergic reaction that is rapid in onset and may cause death; see anaphylaxis article in this supplement), drug rash with eosinophilia and systemic symptoms (dress) syndrome, serum sickness, drug-induced lupus erythematosus (dile) and vasculitis (a heterogeneous group of disorders that are characterized by inflammatory destruction of blood vessels). |
| PubMedID- 23558269 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome is a severe drug-induced hypersensitivity syndrome and may be observed after administration of many drugs. |
| PubMedID- 21103811 | Eight different clinical reaction patterns were noted, namely drug exanthems (46.4 percent), drug rash with eosinophilia and systemic symptoms (18.6 percent), stevens-johnson syndrome/toxic epidermal necrolysis spectrum (14.4 percent), urticaria/angioedema (11.3 percent), acute generalised exanthematous pustulosis (3.1 percent), fixed drug eruptions (3.1 percent), generalised exfoliative dermatitis (2.1 percent) and drug-induced vasculitis (1.0 percent). |
| PubMedID- 22922763 | The original description involved aromatic anticonvulsants and was termed “anticonvulsant hypersensitivity syndrome.” later the name “drug rash with eosinophilia and systemic symptoms” (dress) was coined but this has been replaced by dihs. |
| PubMedID- 21219413 | Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin. |
| PubMedID- 25709746 | 3dress –drug rash with eosinophilia and systemic symptoms. |
| PubMedID- 25360193 | Drug rash with eosinophilia and systemic symptoms (dress) syndrome is a rather distinct severe adverse drug reaction. |
| PubMedID- 22226608 | Background: delayed hypersensitivity is responsible for severe cutaneous adverse drug reactions (cadrs), especially in stevens-johnson syndrome (sjs), toxic epidermal necrolysis, and drug-induced hypersensitivity syndrome (dihs) (also known as drug rash with eosinophilia and systemic symptoms [dress] syndrome). |
| PubMedID- 25669662 | One dose-limiting toxicity was reported (grade 4 drug reaction or rash with eosinophilia and systemic symptoms). |
| PubMedID- 21217791 | Drug rash with eosinophilia and systemic symptoms (dress) after an unrelated donor bm transplant. |
| PubMedID- 24958965 | Ticagrelor-induced pneumonitis and subsequent pulmonary hemorrhage; drug rash with eosinophilia due to boceprevir; hepatitis c reactivation after starting infliximab; hydralazine-associated immune glomerulonephritis; fluoroquinolones and retinal detachment. |
| PubMedID- 24912998 | Dress syndrome (drug rash with eosinophilia and systemic symptoms) is an idiosyncratic reaction (type b), characterized by peripheral eosinophilia and systemic symptoms, such as fever, rash, lymphadenopathy, hepatitis, atypical lymphocytes and elevation of liver enzymes at least twice its normal level or increase of alanine amino transferase (alt) >100 u/l. |
| PubMedID- 25610351 | The cadrs were classified into seven categories; urticaria, angioedema, maculopapular eruption, fixed drug eruption, erythema multiforme, acute generalized exanthematous pustulosis, drug rash with eosinophilia and systemic symptoms syndrome. |
| PubMedID- 25454599 | [drug rash with eosinophilia and systemic symptoms syndrome induced by telaprevir in a patient with chronic hepatitis c virus infection]. |